Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Allograft rejection 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
2 Allograft rejection 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
3 Asthma 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
4 Asthma 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
5 Autoimmune thyroid disease 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
6 Autoimmune thyroid disease 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
7 Cytokine-cytokine receptor interaction 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
8 Cytokine-cytokine receptor interaction 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
9 Cytokine-cytokine receptor interaction 💬
[1] IL5RA 💬 Benralizumab 💬 Benralizumab [5] 44, 45, 98, 162, 299 💬
10 Fc epsilon RI signaling pathway 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
11 Fc epsilon RI signaling pathway 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
12 Hematopoietic cell lineage 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
13 Hematopoietic cell lineage 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
14 Hematopoietic cell lineage 💬
[1] IL5RA 💬 Benralizumab 💬 Benralizumab [5] 44, 45, 98, 162, 299 💬
15 IL-17 signaling pathway 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
16 IL-17 signaling pathway 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
17 Inflammatory bowel disease 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
18 Inflammatory bowel disease 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
19 Intestinal immune network for IgA production 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
20 Intestinal immune network for IgA production 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
21 JAK-STAT signaling pathway 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
22 JAK-STAT signaling pathway 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
23 JAK-STAT signaling pathway 💬
[1] IL5RA 💬 Benralizumab 💬 Benralizumab [5] 44, 45, 98, 162, 299 💬
24 Pathways in cancer 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
25 Pathways in cancer 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
26 Pathways in cancer 💬
[1] IL5RA 💬 Benralizumab 💬 Benralizumab [5] 44, 45, 98, 162, 299 💬
27 T cell receptor signaling pathway 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
28 T cell receptor signaling pathway 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬
29 Th1 and Th2 cell differentiation 💬
[1] IL5 💬 Mepolizumab 💬 Mepolizumab [4] 44, 45, 98, 162 💬
30 Th1 and Th2 cell differentiation 💬
[1] IL5 💬 Reslizumab 💬 Reslizumab [2] 44, 98 💬